Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Use of alerts triggered by patient-reported outcome monitoring improved symptom control for ...

Analysis of Patient Reported Outcomes From PATHFINDER Indicate Minimal Patient Distress Associated with Multi-Cancer Early Detection Testing MENLO PARK, Calif., Jan. 13, 2025 /PRNewswire/ -- GRAIL, ...

When patients provide information about how they are doing, including symptoms, functionality, and quality of life, scientists can use this data, called patient-reported outcomes (PROs), to conduct ...

Patient-reported outcomes (PROs), which assess symptoms, functional status, and quality of life, had independent prognostic value for overall survival in patients with cancer, according to a ...

Additional benefits include improved patient experience and lower utilization of services. (HealthDay News) — Electronic symptom monitoring with patient-reported outcomes (PRO) meaningfully improves ...

Phase I trial of hypofractionated radiotherapy and pembrolizumab in the treatment of muscle invasive/metastatic bladder cancer: Results of the PLUMMB trial. This is an ASCO Meeting Abstract from the ...

Zidesamtinib is an investigational, novel brain-penetrant ROS1-selective inhibitor created with the aim to overcome limitations observed with currently available ROS1 inhibitors. Zidesamtinib is ...

A geriatric oncology example shows how different analytic choices for longitudinal patient-reported outcomes can shift ...

ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results Patients diagnosed with hereditary RC are more prone to ...

Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...

Access to patient-reported outcome (PRO) data significantly improved providers' consistency in assessing adverse events in patients with cancer, with the greatest improvements observed for ...

A large multinational clinical trial has found that giving healthcare providers access to European Organisation for Research and Treatment of Cancer (EORTC) patient-reported outcome (PRO) data ...